Synaptics stockholders approve equity plan increase and elect six directors
At its 2025 Annual Meeting on October 28, 2025, Synaptics stockholders approved amended 2019 Equity and Incentive Compensation and Employee Stock Purchase plans that add 1,900,000 and 1,500,000 shares, respectively, for issuance. They also elected six directors and ratified KPMG LLP as independent auditor for the fiscal year ending June 27, 2026. The increases expand the number of shares the company may issue under these plans, which is relevant to existing shareholders' ownership percentages.
Key points
- Equity plan: 1,900,000 additional shares authorized; 22,007,201 votes for, 10,508,287 against, 25,316 abstentions, 3,956,258 broker non-votes.
- Employee Stock Purchase Plan: 1,500,000 additional shares authorized; 32,417,547 votes for, 110,822 against.
- Six directors elected: Jeffrey D. Buchanan, Keith B. Geeslin, Patricia Kummrow, Vivie Lee, Rahul Patel and James L. Whims.
- Record date September 4, 2025: 39,050,213 shares outstanding; 36,497,062 shares (93.46%) present at the start of the meeting.
The filing
Written by AI on Nov 8, 2026, 1:00 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 28, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.